Corporate Overview

Our company is engaged in the development, formulation and production of branded Bioresonant Phytotherapeutic™ and nutraceutical products for sale in the global Complementary Alternative Medicine ("CAM") and natural product markets. The Company’s production facilities are located in Maui, Hawaii where it operates plant hydrodistillation facilities, focusing on the production of natural products used to restore health and prevent disease.

The Company’s Bioresonant Phytotherapeutic product lines include: Flight Spray®, Hawaiian Healing Mist®, O-Spray™, Traveler’s 1st Aid™, Curecurmin™, Morindasol™, Noni Care™, Ginzeng!®, and Auntie Mahi Poe Poe’s Original La’au Lapa’au Tonics™. The Company’s Nutraceutical division product lines include: Liquid Essence® and Liquid Sense™.

In addition, the Company’s Phytonic Research Program develops market applications for its patented Airponic Growing System™ ("AGS") technology in the phytopharmaceutical, natural product and cosmetics industries. This program utilizes the Company’s proprietary process: "Whole-Plant Biotransformation"- a methodology for enhancing the production of specialty phytochemical compounds produced in plants grown in the AGS System. The AGS is also used as a vertically integrated technology for the enhancement and production of plants processed in its hydrodistillation facilities for use in its Bioresonant Phytotherapeutic and nutraceutical product lines.

Bioponic Phytoceuticals provides natural product and phytochemical production technologies to meet the challenges of the 21st Century. With the establishment of its distillation facilities on Maui, Hawaii, the Company has created production capabilities to meet demands for its Bioresonant Phytotherapeutic and nutraceutical product lines.

Research organizations and pharmaceutical firms worldwide are now responding to the possibilities of major new drug markets based on botanical discoveries. Pharmaceuticals derived from plants account for over $10 billion in sale, annually, and demand for plant-derived medicinals is growing. The Company believes that significant markets will continue develop for new botanically-based medicines.

The recent history of herbal medicine has reflected social trends with the increasing demand for effective treatments for common chronic disorders that are perceived as being both safe and natural. There has, in fact, been a renaissance in herbal medicine over the last 20 years demonstrating as a significant increase in demand for over-the-counter herbal products. Herbal medicine is now moving back to mainstream medicine. Bioponic Phytoceuticals’ products will play a significant role in serving this important emerging market.

With its herbal formulation knowledge and developed extraction production protocols, the Company will continue to have a distinct edge in the development of plant-based products both now and in the future.